Showing posts with label reproductive system. Show all posts
Showing posts with label reproductive system. Show all posts

Wednesday, June 20, 2018

Should Labor be Induced in Extra-Long Pregnancies?

Compared to normal-length pregnancies, pregnancies that go on too long carry a slightly greater risk of fetal death at or near the time of birth. For that reason, physicians sometimes recommend that labor be induced when a pregnancy has gone on longer than normal. But induction of labor may also entail a small risk, especially if there is no sign of impending spontaneous labor. Which is the lesser risk?

To find out, researchers combed all the available data from previous studies of inducing, or not inducing, labor after unusually long gestation (usually 41 weeks). In all, they reviewed 30 studies involving a total of over 12,000 women in 14 countries.

The results? Inducing labor after 41 weeks resulted in fewer infant deaths. It also resulted in fewer caesarean deliveries, though on the other hand it did result in more assisted (operative) vaginal births. All in all, induction of labor after 41 weeks of gestation appeared to be a good choice. However, it was not determined in this study whether there is an optimal time of induction - should it be at 41 weeks, or 42, or even 43?

Based on this analysis, women who experience an extra-long gestation can safely consider induction of labor as an option.

Thursday, March 22, 2018

Rates of STD Infection in the U.S. Continue to Rise

The rates of infection of most STDs rose again in 2016, according to the CDC. Compared to 2015, chlamydia infections were up 4.7%, syphilis infections increased 17.6%, and gonorrhea was up by 18.5%. The increases are part of a trend that started about a decade or so ago.

The only good news is that rates of HIV infection have been trending slightly downward over the past five years. Compared to 2015, the rate of HIV infection declined by 0.1% in 2016.

The dramatic increases in syphilis and gonorrhea infections in 2016 are cause for concern, of course. Sexually active individuals should be aware of these trends and seek to protect themselves accordingly.

Friday, March 9, 2018

Australia May Become the First Country to Eradicate Cervical Cancer

If the current trend continues, Australia may become the first country to virtually eradicate the HPV virus that causes cervical cancer. How did they do it? Health officials credit an aggressive government-financed vaccination campaign begun in 2007 that targeted 12-13 yr.-old girls, combined with a catch-up program to vaccinate older girls and women up to the age of 26 that was completed in 2009.  By 2015, 53% of women in the now 18-35-yr.-old age group had been vaccinated. More importantly, rates of HPV infection have dropped from 22.7% to less than 1.5%. That's a 93% decline in HPV infection rates!

Why did HPV infection rates drop so dramatically when only 53% of the women have been vaccinated so far? It's the well-known "herd effect" - when enough people in a population are immune to a transmissible disease organism, it's much harder for the organism to be transmitted from person to person, even though some people are not yet immunized.

Although health officials have not yet seen a dramatic decrease in the number of cases of cervical cancer, that's because it can take years for cervical cancer to develop after HPV infection. At the moment, the number of cases of cervical cancer is just beginning to decline. Nevertheless, officials are confident that with continued aggressive vaccination against HPV, within 30-40 years cervical cancer will be a thing of the past in Australia.

The full HPV vaccination regimen costs about $400 per person in the U.S.; probably less in a country like Australia with a government-sponsored program. Sounds like a pretty good deal to me.

Thursday, February 8, 2018

New Treatment for a Penile Dysfunction Condition

Peyronie's disease - the disease we never knew existed until there was a cure for it. TV commercials about the condition ask cryptically "Are you curved below the belt?". It took me a minute to figure that one out! In fact, Peyronie's disease is a relatively rare condition in which scar tissue in the penis causes marked curvature of the penis during an erection, leading to painful erections and problems having sex. What causes the scar tissue to develop is generally unknown, although prior physical injury is suspected in many cases.

In December the FDA approved the first non-surgical treatment for Peyronies's disease after reviewing the results of two studies. Shortly thereafter the company producing the treatment, Endo Pharmaceuticals, launched an aggressive disease awareness and product marketing campaign. And why not? There's a lot of money to be made. Treatment will cost $26,000 in addition to the doctor's fees. Treatment involves 8 injections into the penis six weeks apart of Xiaflex, a collagenase derived from the bacterium that causes gangrene.

Endo Pharmaceuticals says that "3-9% of adult males worldwide are estimated to have Peyronie's disease", but no evidence is presented to back that up. Estimated by whom? Sigh. For now we'll just have to put up with those annoying ads.

Friday, January 5, 2018

Does a Frozen Embryo Have an Expiration Date?

How long can a frozen embryo be stored before it is implanted into its potential mother? Does a frozen embryo have an effective "use by" date, like most foods?

Recent evidence suggests that frozen embryos could be stored almost indefinitely, it seems. Case in point: a 25-year old woman recently gave birth to a child after receiving an embryo that was conceived and frozen 25 years ago. In other words, the embryo was conceived and frozen in the same year that its birth mother was born!

There are no official databases of when embryos are frozen and subsequently used, and so there's no way of knowing if this is a record of some sort. The couple chose the embryo after reviewing its biological parents' profiles, because they were interested in a child that would look somewhat like themselves. Only later were they made aware of the embryo's age. The embryo came from a faith-based fertility clinic that focuses on saving, not destroying, embryos.

Reproductive scientists are not surprised that embryos remain viable after long-term storage, although there have been no scientific studies carried out to find that out. The available evidence suggests that embryos are at the greatest risk of damage by the thawing procedure, and not by the length of frozen storage.

Thursday, December 7, 2017

First U.S. Baby Born After a Uterine Transplant

It was bound to happen sooner or later. A U.S. woman who was born without a uterus has just given birth to healthy baby after doctors at Baylor University transplanted a uterus into her last year, according to an ABC news report.

Transplant doctors see it as a significant advance, and indeed it may be. Once perfected, the technique could offer hope to women who for whatever reason do not have a functioning uterus and so cannot experience pregnancy and childbirth. However, it is important to note that the technique is still in the research stage. Several of the very few uterine transplants performed so far have had to be removed because they failed.

I've written about some of the ethical and financial issues related to uterine transplants before (see this blog, Nov. 23, 2015 and Feb. 29, 2016). What do you think?

Monday, October 30, 2017

Underweight Women are at Higher Risk of Early Menopause

A study in Human Reproduction reports that women who are underweight are at higher risk than women of normal weight of going through menopause before age 45.

The study enlisted nearly 80,000 women starting back in 1989. Over the next 22 years, 2,804 of them went through natural menopause. After controlling for several factors including smoking, oral contraceptive use, and pregnancies, the study found that women who had a Body Mass Index (BMI) under 18.5 were 30% more likely to go through menopause before age 45 than women with BMIs between 18.4 and 22.4 (defined as normal weight).

The study does not tell us why a low body weight increases the likelihood of early menopause. And to be clear, menopause is a natural phenomenon for all women, eventually. However, early menopause does have implications for family planning, and it is sometimes associated with other conditions such as osteoporosis later in life. Women who are concerned should consult their doctor.

Monday, September 4, 2017

Sperm Count in Western Males is Declining

Is male sperm count declining? It's been a topic of debate for some time now. The problem is that the decline, if it exists, has been so slow that it has been difficult to measure.

To answer the question of whether or not male sperm count is declining, researchers conducted a massive meta-study (an analysis of many previous studies) of male ejaculate sperm concentration and total sperm count. Authors of the meta-study looked for all previous studies of sperm concentration and sperm count in Western men (men from North America, Europe, Australia and New Zealand) published between 1973 and 2011. In all, the meta-study included data from 185 previous studies involving almost 43,000 Western men over almost 40 years, making it the largest such study ever. In order to avoid problems associated with changing laboratory methods, the authors included only studies that used the same laboratory analysis method throughout.

The results showed a decline of sperm concentration of only 1.4% per year (that's why it was so hard to see in individual studies). But over the nearly 40-year time span, that's a decline of over 50% in ejaculate sperm concentration! Total sperm count declined even more; by 60%, in fact.

Of course, no one has any information yet on just why the decline might be occurring. But with fairly definitive evidence now that it is occurring, we can expect researchers to turn more aggressively to the question of why, and what might be done about it.

Monday, July 10, 2017

Baby Sickened Because Mother Eats Placenta

The Centers for Disease Control and Prevention (CDC) reports that a baby in Oregon was treated for Group B streptococcus infections - twice in a week! - apparently because its mother was ingesting improperly prepared placental pills.

Although the CDC does not recommend placenta consumption, it's a fad in some circles that just won't go away. According to CNN News, devotees include Kim Kardashian and Alicia Silverstone. There is even a group called the Association of Placenta Preparation Arts that claims to have "placenta preparation specialists" who know how to prepare the placenta properly for ingestion. As if there actually is a "proper" method for preparing the placenta for ingestion. Members of the group believe that placenta consumption has benefits including preventing postpartum depression and increasing milk production.

Pardon me, but there is no evidence that these people know what they are doing (see this blog July 19, 2007 and June 13, 2015). Feel free to check out their website, compare it to the CDC report and any available scientific evidence, and make up your own mind if you wish.

Friday, May 19, 2017

Creating Eggs From Skin Cells

Some day it may be possible to produce human babies from skin cells, according to an editorial in Science Translational Medicine.  It's all due to a new technique called in vitro gametogenesis (IVG).

IVG refers to the technique for producing eggs or sperm (gametogenesis) outside the body (in vitro). The technique only became possible because, a decade or so ago, scientists learned how to produce undifferentiated stem cells known as induced pluripotent stem cells (iPSPs) from mature somatic cells.  Since that time iPSCs have been used to create various kinds of specialized somatic cells, including neurons to heart muscle cells.  And just recently, iPSCs derived from mouse tail cells were used to create fully functional gametes (eggs).  When fertilized with sperm, these eggs created by IVG were able to develop into healthy baby mice.  Sperm have not yet been fully developed from iPSCs, but surely they will be.

The ability to produce eggs and/or sperm from somatic cells raises all kinds of possibilities for how the procedure might be used (or misused, depending on your perspective).  If an egg could be grown from a male's skin cell and then fertilized by IVF with sperm from a male partner, gay couples could have babies that were genetically related to both of the males.  Of course a female surrogate mother would be necessary to carry the embryo to term, but surrogate mothers are not uncommon these days. Taking it one step further, if both eggs and sperm could be created from a male's skin cells, the male could (again, with the help of a surrogate) have a child that was entirely genetically his. These are scenarios that may need to be dealt with in your lifetime.  (Note that since females have no Y chromosome, IVG could only produce eggs from a female; never sperm.)

On the positive side, the ability to produce eggs from skin cells could mean that overcoming infertility would become easier and cheaper.  Right now, women undergoing an IVF procedure must undergo a complicated cycle of ovary stimulation and egg retrieval; with IVG, that would be unnecessary.  Furthermore, IVG could be used to produce an almost infinite supply of eggs, whereas only a few eggs are produced with each IVF cycle.

How do you think IVG should be used?

Saturday, February 11, 2017

Improving the Odds of Successful In Vitro Fertilization

During a normal monthly reproductive cycle, the endometrial lining of the uterus undergoes a series of changes that make it receptive to the possible arrival and successful implantation of an early-stage embryo.  Endometrial receptivity only lasts about 12 hours; under natural conditions it coincides with the time that the early-stage embryo would be expected to arrive at the uterus, if in fact an egg was fertilized that month.  It all just happens naturally, without any thought on our part.

For infertile couples who opt for in vitro fertilization (IVF) in an attempt to become pregnant, timing can be critical.  If the embryo is introduced into the uterus at a time when the uterus is not receptive, the whole process can end in failure.  An IVF procedure can cost tens of thousands of dollars, and its not unheard of for couples to try multiple times without success and without knowing why.  One possible reason for multiple failures is that the embryo may not have been introduced into the uterus at precisely the right time.  The 12-hour window of maximum receptivity can occur on different days of the cycle in different women, and in the past there was no way to determine it.

But now there's a test to determine the precise moment of maximum endometrial receptivity.  It's called the endometrial receptivity array (ERA) test.  The test works by analyzing the genetic expression of several hundred of the genes known to be involved in the buildup of the endometrium in preparation for implantation.  The period of maximum expression of these genes coincides with the best time for embryo implantation.  The test has dramatically improved the odds of a pregnancy for couples who had previously experienced multiple IVF failures.

Monday, November 28, 2016

Essure Contraception to Come With a Warning

Not mentioned in Human Biology: Concepts and Current Issues is a type permanent non-surgical contraception for women marketed by Bayer, called Essure.  Essure consists of a pair of small coiled devices placed in the two fallopian tubes through the vagina.  The devices trigger local inflammatory responses that seal off the fallopian tubes within about 3 months, rendering the woman permanently sterile.  When it was first approved in 2002, Essure became the first permanent sterilization procedure that could be done in a doctor's office without general anesthesia or a surgical incision, making it an attractive option to surgical tubal ligation for some women.

Now it appears that Essure will come with an FDA-mandated warning that it may cause unwanted effects in some women, including possible puncture of the fallopian tubes or uterus and intense pain.  The FDA is not requiring that the devices be pulled from the market at this time because the device has been proven safe and effective for most women.  However, the FDA did work with Bayer to develop a 3-page checklist that physicians and patients may find useful in evaluating the risks and benefits of Essure versus surgical tubal ligation.

Bayer, of course, blames any problems associated with Essure on poor skills on the part of doctors implanting the devices.  There could be some truth to that. For most medical procedures, physicians who have done a lot of them tend to have fewer reported complications.  It's always wise to choose your physician carefully.

Friday, November 11, 2016

Medical Abortions Without Visiting an Abortion Clinic

A study is underway in four states (Hawaii, Washington, Oregon, and New York) to determine whether medical abortions can be conducted safely without the woman ever having to visit an abortion clinic.

Currently, women must visit to an abortion clinic for a medical abortion.  After consultation with a physician, the woman is prescribed two pills; the first is given at the abortion clinic, and the second is taken a day later.  Together, the two pills cause a miscarriage.  Medical abortions are FDA-approved during the first 10 weeks of pregnancy; after that, only surgical abortions are allowed.   Nearly a quarter of all abortions in the U.S. are now medical abortions.

In the current study, women will first consult with an abortion provider by video, from the comfort of her own home.  Then certain tests must be completed, including blood work and an ultrasound.  If all goes well, the medical abortion pills will be delivered by mail.

The FDA has approved the study and will be monitoring the safety of the procedure closely.  But pro-life advocates are unlikely to favor FDA approval of medical abortions by videoconference and mail, regardless of how safe it turns out to be.

Thursday, September 1, 2016

Caster Semenya Wins Gold at the Olympics

It has been a long and sometimes humiliating road for Caster Semenya, who won the women's 800-meter race at the 2016 Olympics. That's because Caster is thought to have an intersex condition characterized by ambiguous genitalia and quite possibly high testosterone levels - in other words, she may be a "tweener" in terms of gender. After she won the women's 800 meters race at the 2009 World Games, Caster was subjected to humiliating gender determination - by a committee, no less. Cleared to compete again in 2010, she won a silver medal in the 800 meters race at the 2012 Olympic Games (see this blog Aug. 16, 2012).

In an effort to establish a policy for female athletes that could be applied before competition, not after, in 2011 the International Association of Athletics Federations (IAAF) developed a policy based on testosterone levels. The first test case was a woman named Dutee Chand who was prevented from competing as a woman in 2014 because she had testosterone levels above the limit for females. Ms. Chand appealed the decision to the Court of Arbitration in Sport (CAS), based in Switzerland. In 2015 the CAS ruled in favor of Ms. Chand and suspended the IAAF's policy for two years. The CAS argued that there was insufficient evidence to conclude that women with high testosterone levels benefit from such a performance advantage that they should be excluded from competing as females. The court gave the IAAF two years to provide more persuasive evidence for its policy, if it could.

And that's where we stand today. Based on the CAS ruling, there was no way that a defensible policy defining femaleness for the purpose of athletic competition could have been developed for the 2016 Olympics, and so Caster Semenya was quietly allowed to compete again. In a brief statement, the International Olympic Committee said only that it encourages the IAAF to go back to the CAS "with arguments and evidence to support the reinstatement of it hyperandrogenism rules."

For the record, Caster Semenya has always identified herself as a woman. She wasn't looking for the controversy she caused in 2009, and she wasn't looking for it in 2016. She just wanted to compete. And that, after all, is the spirit of the Olympics.

Monday, July 4, 2016

Prescription Contraceptives Via App or Website

It is now possible to obtain prescription contraceptives without ever having to schedule a visit to a doctor's office. A growing number of websites and apps allow you to fill out your personal and health information online or on an app and then have a videoconference or phone conversation with a licensed doctor; after approval of your prescription, your contraceptives (pills, patches, and in some cases even the morning-after pill) can be shipped directly to you.

Contraceptives are currently available only by prescription. Health professionals believe that contraceptives are so safe that they could be made available over-the-counter. However, over-the-counter availability would require approval from the FDA, an expensive and time-consuming effort most drug companies wish to avoid. In addition, the widespread availability of contraceptives without any medical approval at all would likely meet with opposition from conservative groups.

A few states allow pharmacists to write contraceptive prescriptions, but most do not. Web-and app- based services that connect patients to a doctor without a visit to a doctor' office are yet another way to make contraceptives more readily available. Health professionals hope that by making it easier for women to obtain contraceptives, these web-and app-based services will lead to a further reduction in the rate of unintended pregnancies.

For a description of some of the current websites and apps, see this article in the New York Times.

Monday, June 27, 2016

The Supreme Court Strikes Down a Texas Abortion Law

In a surprise ruling today, the U.S. Supreme Court struck down a Texas abortion access law (see this blog March 2, 2016) that severely restricted access to abortions in that state. The decision was a surprise because the court currently has only eight members, and it was widely believed that the court would be deadlocked on the issue until a ninth justice could be appointed after the presidential election.

Ever since Roe v. Wade, anti-abortionists have introduced legislation in many states designed to restrict access to abortion or make it more difficult. By striking down Texas's law, the court is signaling the states that they cannot restrict access to abortion simply by putting unnecessary obstacles in the way. In the majority opinion, Justice Breyer wrote, "We agree with the District Court that the surgical-center requirement, like the admitting-privileges requirement, provides few, if any, health benefits to women, poses a substantial obstacle to women seeking abortions, and constitutes an "undue burden" on their constitutional right to do so."

This new Supreme Court sets a fairly high bar for anti-abortion legislation; it must not introduce an "undue burden" on what is clearly a constitutional right.

Thursday, April 28, 2016

Whatevever Happened to Filbanserin, the "Female Viagra" Drug?

Last year we were talking about a new libido drug for women, called filbanserin (see this blog, July 2, 2015.). The drug was supposed to improve women's sex lives, giving them the same options men have had for years with Cialis and Viagra. The drug was poised for approval by the FDA, even though there were concerns that it wasn't very effective. Whatever happened to it?

The story of filbanserin (trade name Addyi) is one of hype, greed, and mismanagement. filbanserin was originally under development as a drug to treat depression. Then it was discovered that it seemed to improve some women's satisfaction with their sex lives. Sensing that there might be a really big market for the drug, a small company called Sprout Pharmaceuticals bought the rights to the drug. Twice they tried get it approved by the FDA. When filbanserin was finally approved last August, the company's sales force of 14 national/regional sales managers and 150 sales representatives was all set to promote and sell the drug.

But just one day after FDA's approval of filbanserin, Sprout Pharmaceuticals was bought by an even bigger pharmaceutical company, Valeant Pharmaceuticals for (wait for it...) a whopping $1 billion. (Big fish swallows helpless little fish.) Valeant was making a name for itself on Wall Street by buying up other smaller pharmaceutical companies with patented drugs and immediately raising the drugs' prices. Yes, that's the same Valeant Pharmaceuticals that is now under federal investigation for predatory drug pricing practices.

Valeant's stock price has plummeted 85% since last year. As part of its efforts to save itself, Valeant dismissed the entire Sprout Pharmaceuticals sales force and shelved all plans to sell the drug, saying they might reintroduce the drug later this year. We'll see.

Only a few thousand prescriptions for the drug were ever written. Forget about it: it wasn't a very effective drug anyway.

Saturday, April 9, 2016

The First U.S. Uterus transplant Has Failed

The first attempted uterus transplant in the U.S. has failed. The patient, Lindsay MacFarland, appeared before reporters on February 26, two days after the operation, to thank The Cleveland Clinic and her doctors. But just a day later the uterus was removed because of complications caused by a yeast infection. The announcement of that failure came only yesterday. For more details and photos, see the article in the Daily Mail.

The Cleveland Clinic had anticipated that this would just be the first of ten such surgeries in order to evaluate the potential of such transplants on a wider scale. The protocol may have to be modified in an effort to reduce the chances of future failures.

As I noted in a previous post (see this blog, Nov. 23, 2015), a uterus transplant serves no valid medical purpose other than to allow an infertile woman to experience pregnancy. In a statement to the New York Times last year Mrs. MacFarland, the mother of three adopted children, said, "I crave that experience. I want the morning sickness, the backaches, the feet swelling. I want to feel the baby move. That is something I've wanted for as long as I can remember. "

Do you think it will be worth the risk and expense for surgeons to perfect this surgery? (Mrs. MacFarland's surgery was paid for by a government-funded research study.)

Thursday, April 7, 2016

Easier Access to the Morning-After Pill? Not in Arizona!

Just last week the FDA established new labeling guidelines for the use of mifepristone, the so-called "morning-after pill" (see this blog Apr. 1, 2016). The new labeling guidelines were expected to make mifepristone more widely available in six states that had specifically passed laws requiring physicians to adhere to FDA labeling guidelines when using the drug. The previous labeling guidelines written in 2000 are no longer considered "best medical practice". But they were much more restrictive than the way most physicians were using the drug, so in effect they limited access to medication abortions.

But wait a minute! Just one day after the FDA established the new labeling requirements for mifepristone, Arizona's governor signed into law legislation that declares that mifepristone may only be used in accordance with the old protocol as it existed at the end of 2015. The new law will take effect this Summer, when the legislature is conveniently out of session. Apparently the Arizona legislature knew the FDA ruling was coming and made a preemptive strike against it before adjourning. The intent is clear, for there can be no medical justification for sticking to an outdated protocol that restricts access to a safe and effective drug.

We'll see how this plays out in the courts and in other states that may choose to copy this approach. At the very least, it is likely to delay the availability of mifepristone in Arizona by a year or so.

For more on this subject, see the article in The New York Times.

Friday, April 1, 2016

New Guidelines for the Use of the Morning-After Pill

The FDA has published new guidelines for the use of the "morning-after" pill mifepristone (MifeprexR), used to affect a medication abortion. The new guidelines will permit the pill to be used up to 10 weeks after pregnancy, three weeks longer than previously permitted. The new guidelines will also require only two visits to a physician for a full course of treatment, making the drug easier to obtain and use. Many doctors had already been using mifepristone according to the new guidelines (meaning that they were using it "off-label" at the time), because it has been known for years that the pill is safe and effective up to 10 weeks after pregnancy.

The new FDA guidelines are a setback for the anti-abortion movement. In an effort to make access to mifepristone as difficult as possible, anti-abortion advocates had convinced the legislators of six states (Arizona, Arkansas, Ohio, Oklahoma, North Dakota, and Texas) to pass laws prohibiting off-label use of the drug. The unspoken goal of these laws was to make it harder to obtain and use mifepristone by forcing patients to see a physician three or more times instead of just twice and limiting the drug's use to just seven weeks after pregnancy. The tactic worked; one study found that medication abortions fell by more than 80% in Ohio after introduction of the restrictive law in that state, according to CBS News.

Under the new guidelines, the way that most physicians currently prescribe mifepristone will no longer be "off-label".  As a result, medication abortions should again become more common in those six states that had attempted to restrict them.